These are the brainds it acquired from Swiss drug firm Novartis in Japan, earlier this year for $293 mn. The company said it has signed a strategic distribution alliance with Mitsubishi Tanabe Pharma Corporation for these 14 prescription brands.

Sun Pharma announces phased transfer of manufacturing and marketing rights of 14 brands

Leave a Reply

Your email address will not be published. Required fields are marked *